Drug Approvals
🇺🇸 FDA Page 10FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 109–120 of 665 articles
FDA Declines Guidance on Foreign Drug Imports: Impact on Pharma BD and Investors
FDA · 6 min
Dr. Sarah MitchellNew Hormone Regimen Shows Promise for Prostate Cancer Surgery Patients: Study Insights
FDA · prostate cancer · 6 min
Dr. Sarah MitchellThe Hidden History of BPC-157: Unlocking Pharma Opportunities
FDA · regenerative medicine · 6 min
Dr. Sarah MitchellEisai's Leqembi Sales Forecast: A Turning Point?
FDA · Alzheimer's · 7 min
Dr. Sarah MitchellFDA seeks to cut repeat work for gene therapy developers
FDA · gene therapy · 6 min
Dr. Sarah MitchellOphthalmology Pipeline Milestones for Q2 2026: Key Catalysts and Investor Insights
FDA · ophthalmology · 6 min
Dr. Sarah MitchellFDA Hold Puts Aardvark Prader-Willi Drug in Limbo: Implications for Pharma BD
FDA · Prader-Willi syndrome · 8 min
Dr. Sarah MitchellEbola Response Shift: Trump Administration's New Playbook and Pharma Implications
FDA · Ebola · 7 min
Dr. Sarah MitchellReal-World Data from EHRs and Claims: Strengths, Limitations, and Regulatory Impact
FDA · 7 min
Dr. Sarah MitchellThe Market for Monoclonal Antibodies: Trends, Challenges, and Opportunities in 2024
FDA · chronic diseases · 7 min
Dr. Sarah MitchellA Brief History of Major Events in Oncology
oncology · 9 min
Dr. Sarah MitchellASCO: Pfizer scores in lung, colorectal and prostate cancer but key readouts still to come
ASCO · oncology · 8 min
Dr. Sarah MitchellExplore intelligence